Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Collegium Pharmaceutical Inc    COLL

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/19/2017 06/20/2017 06/21/2017 06/22/2017 06/23/2017 Date
11.12(c) 11.27(c) 11.91(c) 11.93(c) 12.84(c) Last
396 308 571 675 466 827 555 149 1 028 275 Volume
+4.81% +1.35% +5.68% +0.17% +7.63% Change
More quotes
Financials ($)
Sales 2017 24,8 M
EBIT 2017 -89,3 M
Net income 2017 -89,3 M
Debt 2017 -
Yield 2017 -
Sales 2018 71,1 M
EBIT 2018 -54,4 M
Net income 2018 -50,8 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 15,3x
Capi. / Sales2018 5,32x
Capitalization 378 M
More Financials
Company
Collegium Pharmaceutical, Inc. is a clinical-stage pharmaceutical company, which focuses on the development of proprietary, late stage pharmaceutical products.These products target market opportunities through formulation based product improvements protected by intellectual property.It builds a... 
Sector
Pharmaceuticals
Calendar
08/16Earnings Release
More about the company
Surperformance© ratings of Collegium Pharmaceutical I
Trading Rating : Investor Rating :
More Ratings
Latest news on COLLEGIUM PHARMACEUTICAL I
06/09 COLLEGIUM PHARMACEUTICAL : Announces Scientific Presentations at the 2017 Intern..
06/08 Collegium Announces Scientific Presentations at the 2017 International Confer..
06/01 COLLEGIUM PHARMACEUTICAL : Pharma (COLL) Appoints Joseph Ciaffoni as COO
06/01 Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medic..
05/31 COLLEGIUM PHARMACEUTICAL, INC : Change in Directors or Principal Officers, Submi..
05/31 COLLEGIUM PHARMACEUTICAL : Announces the Appointment of Joseph Ciaffoni as Chief..
05/30 Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Off..
05/23 Collegium to Present at Upcoming Investor Conferences
05/16 INSIDER TRADING ACTIVITY COLLEGIUM P : COLL) – Insider Bought 10,000 share..
05/10 COLLEGIUM PHARMACEUTICAL : posts 1Q loss
More news
Sector news : Pharmaceuticals - NEC
06/23DJSAMSUNG ELECTRONICS : Makes Play for Drug Market With Version of Humira -- Updat..
06/23DJSAMSUNG ELECTRONICS : Makes Big Play in Drug Market With Cheaper Version of Bloc..
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/23 China's ICBC says checks of loans to big acquirers are routine
06/22 GSK'S NEW CEO AIMS TO DIVEST SPORTS : sources
More sector news : Pharmaceuticals - NEC
Latest Tweets
06/20Collegium Pharmaceutical $COLL and Pacira Pharmaceuticals $PCRX Head to Head .. 
06/20-$0.80 Earnings Per Share Expected for Collegium Pharmaceutical, Inc. $COLL T.. 
06/17Collegium Pharmaceutical, Inc. $COLL Expected to Announce Quarterly Sales of .. 
06/13FDA's Gottlieb taking aim at opioid epidemic, wants post-market studies to co..
1
06/12Collegium Pharmaceutical, Inc. $COLL Receives Buy Rating from Janney Montgome.. 
More tweets
Qtime:9
News from SeekingAlpha
06/13 FDA's Gottlieb taking aim at opioid epidemic, wants post-market studies to co..
06/09 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
06/09 Buying picks up in Collegium on market exit of Endo's Opana ER; shares ahead ..
06/09 KemPharm on deck to present data on hydromorphone prodrug KP511
05/30 New operating chief at Collegium
Advertisement
Chart COLLEGIUM PHARMACEUTICAL I
Duration : Period :
Collegium Pharmaceutical I Technical Analysis Chart | COLL | US19459J1043 | 4-Traders
Full-screen chart
Technical analysis trends COLLEGIUM PHARMAC...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 22,2 $
Spread / Average Target 73%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael Thomas Heffernan Chairman, President & Chief Executive Officer
Joseph J. Ciaffoni Chief Operating Officer & Executive Vice President
Paul Brannelly Chief Financial Officer & Executive Vice President
Gino Santini Independent Director
David J. Hirsch Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
COLLEGIUM PHARMACEUTIC..-17.53%378
JOHNSON & JOHNSON18.42%367 520
NOVARTIS13.09%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER5.20%203 487
MERCK AND COMPANY12.38%180 958
More Results